Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sanofi crawled time : 14:15 save search
Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides Updates on Commercial Launch and Timing for Congenital Hyperinsulinism and Short Bowel Syndrome Phase Three Clinical Studies
Published: 2021-11-11 (Crawled : 14:15) - globenewswire.com
SNYNF | $92.966 630
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
|
| O: -2.91%
H: 0.0%
C: -8.51%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
financial results results insulin syndros
YOOBIC Recognized in Leading Analyst's Report on Retail Associate Enablement
Published: 2021-11-09 (Crawled : 14:15) - prnewswire.com
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
Ichnos Sciences Appoints Sonia Quaratino, M.D., Ph.D., To Its Board Of Directors
Published: 2021-11-09 (Crawled : 14:15) - biospace.com/
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
Sanofi completes acquisition of Kadmon
Published: 2021-11-09 (Crawled : 14:15) - globenewswire.com
MC | $51.54 -0.37% 82K
|
Finance
|
| O: -0.63%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
acquisition
The Talent Enterprise: The Thriving Index® is Now a British Psychological Society (BPS) Registered Test
Published: 2021-11-04 (Crawled : 14:15) - prnewswire.com
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
test
BioSpace Movers & Shakers, Oct. 29
Published: 2021-10-29 (Crawled : 14:15) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: -0.6%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.06%
H: 1.32%
C: 0.64%
space spac
Onchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer
Published: 2021-10-26 (Crawled : 14:15) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
pharma
Regeneron, Sanofi on a Roll as Dupixent Scores Second Consecutive Phase III Win
Published: 2021-10-25 (Crawled : 14:15) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: 1.02%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.89%
H: 0.26%
C: -0.12%
dupixent
Global Heart Failure Drugs Market to Reach $10.2 Billion by 2026
Published: 2021-10-13 (Crawled : 14:15) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
AZNCF | $135.94 770
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
PFE A | $25.84 -0.27% 8.9M
|
Health Technology
|
| O: -0.24%
H: 0.38%
C: -0.79%
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: 0.46%
H: 0.62%
C: 0.08%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.08%
H: 1.43%
C: 0.87%
GSK | $39.935 -1.4% 900K
|
Health Technology
|
| O: -0.57%
H: 1.61%
C: 0.99%
BMY | $48.35 -0.33% 2.1M
|
Health Technology
|
| O: 0.0%
H: 0.58%
C: 0.02%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.5%
H: 1.04%
C: 0.33%
EXEL 4 | $22.8 0.44% 290K
|
Health Technology
|
| O: 0.0%
H: 0.4%
C: 0.23%
AZN | $68.39 -0.5% 1.1M
|
Health Technology
|
| O: -0.43%
H: 1.08%
C: 0.73%
heart drug
Denali Moving Forward with Sanofi-Partnered ALS Candidate
Published: 2021-10-07 (Crawled : 14:15) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: -4.14%
H: 5.79%
C: 5.79%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.21%
H: 0.95%
C: 0.62%
als
Clinical Catch-Up: September 27-October 1
Published: 2021-10-04 (Crawled : 14:15) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
NEA's Eczema Awareness Month 2021 Explores The Heterogeneity Of This Life-altering Skin Disease That Burdens 1 In 10 Adults And Children In The USA
Published: 2021-10-01 (Crawled : 14:15) - prnewswire.com
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
disease eczema children skin xin
Model N Positioned as a Leader in the 2021 IDC MarketScape for B2B Price Optimization and Management Applications
Published: 2021-09-24 (Crawled : 14:15) - modeln.com
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: 0.0%
application positive
BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on the African Continent
Published: 2021-07-26 (Crawled : 14:15) - globenewswire.com
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.14%
H: 0.33%
C: 0.02%
BNTX | $86.66 -1.4% 360K
|
Health Technology
|
| O: 2.67%
H: 2.84%
C: -1.12%
disease infectious disease
Clinical Nutrition Market Size to Reach Revenues of USD 89.98 Billion by 2026 - Arizton
Published: 2021-07-07 (Crawled : 14:15) - prnewswire.com
PRGO A | $30.15 0.07% 400K
|
Health Technology
|
| O: -0.13%
H: 0.53%
C: 0.34%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.43%
H: 0.39%
C: 0.0%
nutrition ev
Future Market Insights' 257 Pages Automated Suturing Devices Market Survey Identifies Demand for Minimally-Invasive Surgeries a Chief Growth Driver
Published: 2021-07-05 (Crawled : 14:15) - prnewswire.com
SNY | $46.19 0.57% 580K
|
Health Technology
| Email alert
Add to watchlist
MDT | $79.3 -1.16% 2.4M
|
Health Technology
| Email alert
Add to watchlist
ev growth device
New Soliqua 100/33 data shows improved blood sugar control without weight gain versus premixed insulin
Published: 2021-06-28 (Crawled : 14:15) - prnewswire.com
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
blood insulin
As India Burns Amid a Lethal 2nd Wave, It's Now Evident that the World Has Failed in Ensuring Equitable Access to Vaccines. While Vaccine Doses Reach 9.7 Billion by 2025, Will They be Equitably Distributed?
Published: 2021-05-20 (Crawled : 14:15) - prnewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.08%
H: 0.97%
C: 0.66%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 1.32%
H: 1.12%
C: 0.92%
NVAX | $4.06 -1.46% 1.1M
|
Health Technology
|
| O: 1.39%
H: 2.66%
C: 1.58%
MRNA S | $105.08 1.18% 980K
|
Health Technology
|
| O: 1.22%
H: 4.31%
C: 3.78%
india vaccine
Translate Bio Presents Preclinical Results in Primary Ciliary Dyskinesia (PCD) at American Thoracic Society (ATS) 2021 International Conference
Published: 2021-05-18 (Crawled : 14:15) - globenewswire.com
TBIO | $0.386 -5.85% 3.5K
|
Health Technology
|
| O: 0.0%
H: 6.94%
C: 3.41%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.22%
H: 0.1%
C: -0.26%
results skin conference preclinical pre-clinical
Phase 3 Data Presented at ATS 2021 Show REGEN-COV™ (casirivimab with imdevimab) Reduced Risk of Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients
Published: 2021-05-17 (Crawled : 14:15) - prnewswire.com
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
REGN | $895.57 -0.33% 180K
|
Health Technology
|
| O: -0.03%
H: 1.84%
C: 1.41%
covid risk casirivimab phase 3
Gainers vs Losers
| 51% | 49% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
DYNT | $0.5255 41.87% 18M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
MCBC | $13.795 38.92% 820K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.